Intravenous administration of RNA suppresses the induction of delayed-type hypersensitivity (DTH) to tumor-associated antigens. Academic Article uri icon

Overview

publication date

  • August 1, 2000

Identity

Digital Object Identifier (DOI)

  • 10.1046/j.1523-1747.2000.00abs-9.x

PubMed ID

  • 10951265

Additional Document Info

volume

  • 115

issue

  • 2